A Single-Arm, Phase I Trial Investigating Adaptor-Controlled CAR T-Cell Therapy (FITC CAR-T+FITC-Folate CAM) in Patients with Folate-Receptor Positive Osteosarcoma

Trial Profile

A Single-Arm, Phase I Trial Investigating Adaptor-Controlled CAR T-Cell Therapy (FITC CAR-T+FITC-Folate CAM) in Patients with Folate-Receptor Positive Osteosarcoma

Planning
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2018

At a glance

  • Drugs CAR-T cell therapies (Primary)
  • Indications Osteosarcoma
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 25 Jul 2018 According to Endocyte media release, the IND filing is anticipated in the fourth quarter of 2018.
    • 26 Feb 2018 According to an Endocyte media release, the company expects to begin this trial in the fourth quarter of 2018 (4Q 2018).
    • 10 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top